IP Library Granted Patent US 11,202,748
Granted Patent B2
US 11,202,748 · App. 16/549,106 · Granted Dec 21, 2021

Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Inventors: Michael Einziger (Malibu, CA); Ann Marie Simpson (Malibu, CA)
Assignee: Versicolor Technologies, LLC
A61K8/492A61K8/4926A61K8/4953A61K8/4973A61K31/404A61K31/407A61K31/519A61P17/16A61Q17/04A61Q19/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,202,748
App. No.
16/549,106
Granted
Dec 21, 2021
Kind
B2
Abstract

The present invention relates to compounds, compositions, and methods for modulating skin pigmentation and treating or preventing UV-induced skin damage, erythema, aging of the skin, sunburn, and hyperpigmentation in a subject. The compounds, compositions, and methods of the present invention generally involve Malassezia -derived compounds, including malassezin and indirubin, and/or chemical analogs thereof. Other applications of the compounds and compositions disclosed herein include, but are not limited to, improving hyperpigmentation caused by a hyperpigmentation disorder, inducing melanocyte apoptosis, and modulating arylhydrocarbon receptor (AhR) activity, melanogenesis, melanin production, melanosome biogenesis, melanosome transfer, melanocyte activity, and melanin concentration.

Claims (20)

1. A method for brightening skin in a subject comprising contacting the subject with a composition, wherein the composition comprises one or more compounds selected from the group consisting of:

or a crystalline form, hydrate, or pharmaceutically or cosmetically acceptable salt thereof.

2. The method of claim 1 , wherein the composition comprises a compound selected from the group consisting of:

or a crystalline form, hydrate, or pharmaceutically or cosmetically acceptable salt thereof.

3. The method of claim 1 , wherein the composition comprises a compound selected from the group consisting of:

or a pharmaceutically or cosmetically acceptable salt thereof.

4. The method of claim 1 , wherein the composition comprises a compound selected from the group consisting of:

or a pharmaceutically or cosmetically acceptable salt thereof.

5. The method of claim 1 , wherein the composition comprises a compound of the following structure:

or a pharmaceutically or cosmetically acceptable salt thereof.

6. The method of claim 1 , wherein the composition comprises a compound of the following structure:

or a pharmaceutically or cosmetically acceptable salt thereof.

7. The method of claim 1 , wherein the composition comprises a compound of the following structure:

or a pharmaceutically or cosmetically acceptable salt thereof.

8. The method of claim 1 , wherein the composition comprises a compound of the following structure:

or a pharmaceutically or cosmetically acceptable salt thereof.

9. The method of claim 1 , wherein the composition comprises a compound of the following structure:

or a pharmaceutically or cosmetically acceptable salt thereof.

10. The method of claim 1 , wherein the composition comprises a compound of the following structure:

or a pharmaceutically or cosmetically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2019
From: EINZIGER, MICHAEL; SIMPSON, ANN MARIE
To: VERSICOLOR TECHNOLOGIES, LLC
Reel/Frame 050959/0905 →
Continuity (3)
Provisional Application 62722412 · Aug 24, 2018
Provisional Application 62742657 · Oct 8, 2018
Related Publication 20200060952A1 · Feb 27, 2020
Cited By (2)
US 12,458,577 US 12,497,385